Drug Profile
Somatropin biosimilar - Bio-Ker
Alternative Names: Recombinant somatropin - Bio-KerLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Bio-Ker
- Class Growth hormones; Hormonal replacements; Obesity therapies; Recombinant proteins
- Mechanism of Action Human growth hormone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Unspecified
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Undefined in Italy
- 11 Sep 2013 Investigation in Undefined indication in Italy (controlled release formulation)
- 11 Sep 2013 Phase-I clinical trials in Undefined indication in Italy (unspecified route)